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Abstract - Patients with end-stage renal disease (ESRD) include a significant percentage of malnourished patients with 
other risk factors: dyslipoproteinemia, insulin resistance, increased oxidative stress and inflammation that together impair 
endothelial function. Abnormal polyunsaturated fatty acids (PUFA) patterns are reported in patients with ESRD. The ba-
sic mechanisms of these disorders are connected with changes in cell functions at the membrane level. Vascular smooth 
muscle cell proliferation plays an important role in the pathogenesis of atherosclerosis. We have examined the association 
between atherosclerotic risk factors and nutritional status in hemodialysis (HD) patients. Mortality was followed for up 
to 18 month. Forty-three HD patients were examined (20 males, 23 females, ages 55±12 years). Nutritional and inflam-
matory markers, including serum concentrations of C-reactive protein (CRP), tumor necrosis factor alpha (TNF-alpha), 
and interleukin 6 (IL-6), were measured. There was significant positive correlation between the plasma albumin level and 
CRP. Significant correlation was found between plasma the cholesterol level and some PUFA. Increasing inflammation 
and endothelial dysfunction predict the development of vascular disease. We report on the relationship between inflam-
matory markers and nutritional parameter, indices of atherosclerosis and other cardiovascular risk factors in patients on 
hemodialysis.
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INTRODUCTION
Malnutrition and inflammation are associated with 
end-stage renal disease (ESRD). IL-6 and TNF-al-
pha powerfully predict death from cardiovascular 
disease in dialysis patients as well as the progression 
of vascular injury. Atherosclerosis and inflamma-
tion have similar basic mechanisms involving the 
adhesion of leukocytes to the vascular endothelium 
in their early phases. Major predictors of the clini-
cal outcome in dialysis patients are protein-energy 
malnutrition (PEM) and inflammation. A common 
mechanism for the development of cardiovascular 
disease and malnutrition in dialysis patients can be 
cytokine activation (Stenvinkel et al., 2001; Zim-
mermann et al., 1999; Bologa et al., 1998; Kaizu et 
al., 1998).
Inflammatory states in end stage renal disease 
(ESRD) are associated with an elevation of serum 
acute phase proteins, including CRP and some 
pro-inflammatory cytokines such as IL-6 and TNF 
alpha (Stenvinkel et al., 2001;Ross, 1999).  IL-6 is 
reported to play a central role in the pathophysiol-
ogy of the adverse effects of inflammation in ESRD 
patients. The increased activation of inflammatory 
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cytokines such as IL-6 and TNF-alpha, may cause 
muscle breakdown and hypoalbuminemia, and may 
be involved in atherogenesis (Ebisuri et al., 1995; 
Tsujinaka et al., 1996; King et al., 1998; Stenvinkel 
et al., 1999).
Dyslipidemia is one of the possible risk fac-
tors for advanced atherosclerosis in patients with 
chronic renal failure. Abnormal phospholipid me-
tabolism may play an important role in the pro-
gression of atherosclerosis in patients with renal 
failure. The total concentration of serum non-
esterified fatty acids (NEFA) plays an important 
role in the pathogenesis of cardiovascular disease 
(CVD). Individual circulating NEFA have achieved 
less scientific focus in relation to atherosclerosis 
compared to total NEFA. These basic discoveries 
help us in understanding the damage process of 
the endothelium and the appearance of its dysfunc-
tion by the inflammation and lipid peroxidation 
processes. A strong link exists between chronic 
inflammation and nutritional markers in HD pa-
tients (Li et al., 2003; Lowrie et al., 1990). The bio-
logical effects of n-3 fatty acids have been shown 
in studies of animals and humans in which anti-
inflammatory and antithrombotic effects could be 
of relevance in HD patients. It is widely accepted 
that a dietary intake of n-3 PUFA or fish oil as 
their dietary sources has beneficial health effects 
on sick and healthy individuals. A great number of 
clinical studies have shown that the intake of n-3 
fatty acids reduces the incidence of cardiovascular 
events and plays an important role in the preven-
tion of inflammatory and autoimmune disorders 
(Simopoulos et al., 1991; Burr et al., 1989).
HD patients have an impaired essential fatty acid 
status, as well as a high level of oxidative stress, and 
they are very often malnourished with a high risk for 
developing cardiovascular pathology. The primary 
aim of our study was to establish the association be-
tween markers of inflammation and atherosclerosis 
and the parameters of malnutrition in HD patients. 
The secondary aim of this study was to determine 
the mortality rate, which was followed for up to 18 
month. 
MATERIALS AND METHODS
We examined 43 HD patients (mean age 55±12 years, 
mean dialysis duration 47±8 months) who were pro-
spectively followed-up for 18 months and all cause 
and cardiovascular mortality were registered. The 
patients had been treated with hemodialysis three 
times a week for at least 6 months. Patients with 
diabetes, acute infections and malignancies were ex-
cluded from the study. The duration of dialysis was 
defined as the number of months from the initiation 
of chronic hemodialysis to the time of laboratory 
data collection. All blood samples were obtained im-
mediately before the dialysis session after an 8-hour 
fast on a mid-week dialysis session. Plasma levels of 
albumin, creatinine, hemoglobin, IL-6, TNF-α, high 
sensitivity CRP, total cholesterol, triglyceride, HDL-
cholesterol, LDL cholesterol and PUFA content of 
red cell membrane phospholipids were measured at 
the start of the study. Plasma albumin, creatinine and 
lipids were measured by routine laboratory methods. 
Plasma CRP level, TNF-α and IL-6 were measured by 
enzyme-linked immunosorbent assay kits (ELISA). 
The total fatty acids composition was determined by 
gas chromatography (GS) in the methyl esters form. 
GS analysis was performed on a VARIAN chroma-
tographer, Model 1400.
The body mass index (BMI) was recorded. Lean 
body mass (LBM) was measured by bioelectric im-
pedance (BIA). We used standard Doppler echo ex-
aminations to determine plaques on the carotid ar-
teries.
The University Clinical Research Ethics Com-
mittee approved the study. All 43 hemodialysis pa-
tients recruited from our unit gave written informed 
consent.
Statistical analysis
All statistical analysis was performed with Stat 6.0 
software package on MS Windows (Stat soft Inc., 
Novi Sad Serbia). The t-test and Mann-Whitney test 
were applied for statistical comparisons between 
groups. Correlations were tested with regression 
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Table 1.Comparison of investigated parameters between groups according BMI tertiles
Variables 1st tertile (group I) 3st tertile (group II)
Number 19 23
Albumin g/L ٭31±3.01 33±3.21
TNF-α pg/ml 2.08±1.65 1.95±1.53
IL-6 pg/ml ٭4.50±4.19 3.41±3.39
Carotid plaques % ٭62 39
CVD % ٭89 72
P should be presented as < 0.05٭
Table 2. Comparison of inflammatory markers between groups
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analysis and Pearson’s partial correlation. Mortality 
was analyzed with Kaplan-Meier curves according 
CRP tertiles values.
RESULTS
The group of well nourished of HD patients with 
higher levels of lean body mass had better nutri-
tional parameters and lower levels of inflammatory 
parameters (Table 1).These patients presented BMI 
and other nutritional parameters significantly higher 
than patients with lower levels of LBM. Malnour-
ished patients had significantly increased cardiovas-
cular disease and carotid plaques.  
Inflammatory markers (CRP, IL-6 and TNF-α) 
were higher in malnourished patients and these dif-
ferences were significant compared to well-nourished 
group (Table 2). 
The plasma cholesterol value correlated with 
some PUFAs (Table 3). There were negative correla-
tions with fatty acid, namely 20:2(n-6) and fatty acid, 
namely 20:5(n-3) and 22:5(n-3). 
There was correlation between the plasma CRP 
and albumin value. There were strong positive cor-
relations between LDL-cholesterol and other lipids 
(cholesterol and triglyceride). HDL-cholesterol neg-
atively correlated with dialysis duration and triglyc-
erides. The presence of plaques positively correlated 
with age and triglyceride level and negatively corre-
lated with HDL-cholesterol level (Table 4).
A high plasma level of CRP (>5mg/dL) indicated 
an increased risk of mortality. The highest risks of 
mortality were reached in patients with high CRP 
plasma values in the III tertiles (Fig. 1).
DISCUSSION
This cross-sectional study confirmed an atheroscle-
rotic risk in a high percentage of HD patients. The 
characteristics of these patients, such as elevated 
plasma lipids, nutritional parameters (dry weight, 
lean body mass and BMI), inflammation and vas-
cular disease (presented as macroangiopathy), were 
found to be significant predictors of mortality and 
comorbidity. Many studies have examined inflam-
Table 4. Correlation matrix:
Variables CRP albumin age Duration HD creatinine trigliceride cholesterol HDL-chol. LDL-chol. BMI plaques
CRP - -0.4897** 0.2511 0.1679 -0.0657 -0.0807 0.0727 -0.0501 0.1088 0.0497 0.2952
albumin - 0.0132 0.0363 0.0363 0.2107 -0.0303 -0.0737 0.0548 0.1038 -0.0390
age - -0.0211 -0.3403* 0.2316 0.1372 -0.0733 0.0646 0.2483 0.4242**
Duration HD - -0.0072 0.1067 -0.1848 -0.4411** 0.0262 -0.1413 0.1924
creatinine - -0.1934 -0.1476 0.0762 -0.1374 0.1696 -0.1876
trigliceride - 0.5447** -0.5171** 0.5293** -0.0009 0.3424*
cholesterol - -0.0995 0.7990** -0.0750 0.2357
HDL-chol. - -0.2934 -0.0228 -0.3218*
LDL-chol. - -0.1174 0.1931
BMI - 0.0635
plaques -
 *  Significant at the level of 5%
 ** Significant at the level of 1%
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matory markers in the process of atherosclerosis. The 
initiation of the inflammatory process in ESRD can 
be associated with an elevation of serum acute-phase 
proteins, including CRP and some pro-inflammatory 
cytokines such as IL-6 and TNF-α. IL-6 is reported 
to play a central role in the pathophysiology of the 
adverse effects of inflammation in ESRD patients. 
Increased activation of inflammatory cytokines, 
such as IL-6 and TNF-α, may cause muscle break-
down and hypoalbuminemia and may be involved 
in atherogenesis (Stenvinkel et al., 2001; Ross, 1999; 
Ebisuri et al., 1995; Stenvinkel et al., 1999). The risk 
of metabolic and cardiovascular disorder was greater 
when the serum albumin concentration was lower.  
It was also evident that most of the classical risk 
factors associated with a tendency to atherosclerotic 
disease in the general population also play a role in 
HD patients. Two of these factors, malnutrition and 
inflammation, are also identified in many clinical 
studies. It is well recognized that malnutrition and 
hypoalbuminemia are important predictive factors of 
mortality in patients with ESRD. In addition, high con-
centrations of acute-phase proteins (CRP) are strongly 
associated with death within 1 year in pre-dialysis and 
dialysis patients. In our study, there was also an as-
sociation between the CRP and albumin level. Fluid 
overload and congestive heart failure may be other 
contributors to increased inflammatory responses in 
HD patients (Li et al., 2003; Lowrie et al., 1990). 
It is now known that chronic inflammation in-
creases the risk of premature atherosclerosis and car-
diovascular disease in patients with chronic kidney 
disease. Correction of the nutritional status in HD 
patients improves the inflammatory state and de-
creases the plasma concentrations of inflammatory 
markers and other parameters that contribute to car-
diovascular disease. 
Malnourished dialysis patients more often have 
cardiovascular disease, carotid plaques and elevated 
Months                                                                                   p=0.0161
Fig. 1. Cumulative survival and CRP values. Cumulative survival curves estimated from the Kaplan-Meier model according to CRP 
tertiles.  
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inflammatory cytokines, which all may increase the 
risk of atherosclerotic vascular disease. These data 
suggested that the inflammatory markers in mal-
nourished HD patients identify patients at high risk 
of comorbidity and mortality. The degree of inflam-
mation correlates with disease severity. 
Inflammation was associated with indices of 
malnutrition and an atherogenic lipid, and may con-
tribute to the high frequency of cardiovascular dis-
ease in HD patients. End stage renal disease leads 
to a reduction in lean body mass, which contributes 
negatively to the outcome in the HD population.
In this study, we have shown that HD patients 
had reduced PUFAs in the red cell phospholipids. 
This study has demonstrated the high prevalence 
of malnutrition, inflammation, carotid plaques and 
cardiovascular disease. Malnourished dialysis pa-
tients more often have cardiovascular disease, ca-
rotid plaques and elevated inflammatory cytokines, 
all of which may increase the risk of atherosclerotic 
vascular disease.
In our previous study, we observed a reduced 
content of essential fatty acids in the red cell mem-
brane phospholipids. In the present study, two sig-
nificant findings were observed: reduced levels of 
some nutritional parameters (indicative of malnutri-
tion) and increased plasma inflammatory markers 
(IL-6 and TNF-a). These data indicate that PUFA 
deficiency may be associated with malnutrition and 
inflammation in these patients.
Phospholipids play a central role in membrane 
function. The length and degree of unsaturated fatty 
acids are determinants of enzyme activity. The acti-
vation of peroxisome proliferator-activated receptors 
might be a possible mechanism for the downregula-
tion of inflammatory markers with supplementation 
of n-3 fatty acids. 
These data indicate that PUFA deficiency may 
be associated with increased inflammatory cy-
tokines, and their levels after treatment may reflect 
on better clinical outcome. The red cell membrane 
is an example of plasma membrane. It is very simi-
lar to the vascular endothelium. A decrease of the 
PUFA content in membrane phospholipids reduc-
es liquidity and the mechanical properties of cell 
membranes. Such a defect in the endothelial mem-
brane could cause vascular dysfunctions as has been 
demonstrated in rats. This suggests that the pathol-
ogy of the inflammatory process is associated with 
the incorporation of EPA and DHA into membrane 
phospholipids (Sellmayer et al., 1995; Koorts et al., 
2002).
The importance of lipid level as a risk factor in 
HD patients is more complex and depends on other 
factors, such as nutritional parameters and inflam-
matory processes. IL-6 is a central mediator of cardi-
ovascular risks associated with many diverse condi-
tions (Perunicic et al,, 2008; Perunicic et al., 2007).
Peck suggests that HD patients may have in-
creased prostaglandin E2 (PGE2) values and fatty 
acid profiles indicative of essential fatty acids defi-
ciency (Peck et al., 2007). Sinziger and Leitner have 
shown that the metabolism of arachidonic acid shift-
ed from the cyclooxygenase pathway to the lipoxy-
genase pathway in renal patients. Higher level of 
eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA) block the lipoxygenase pathway of ei-
cosanoid production, pushing the arachidonic acid 
metabolism to the cyclooxygenase pathway. This 
pathway leads to an increased level of prostaglandin 
E2 (PGE2) that acts less inflammatorily than leukot-
riene B4 (Peck et al., 1997; Sinzinger et al., 1987).
Our study has demonstrated the high prevalence 
of malnutrition, inflammation, carotid plaques and 
cardiovascular disease in HD patients. The results 
suggest that inflammation is an important process 
in promoting atherosclerosis. The present study 
showed that a higher CRP level was significantly 
associated with a higher risk of mortality in mal-
nourished hemodialysis patients. We calculated 
the mortality risk based on the one-point measure-
ments of CRP at the start of observation, and not 
on averaged values during the follow up. This is a 
limitation of the study.
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CONCLUSION
Malnutrition is of greater prognostic importance in 
the survival of HD patients. However, serum albu-
min is influenced by factors other than malnutrition, 
and high CRP is correlated with low serum albumin 
in malnourished dialysis patients. The observations 
from this study may offer a basis for future research 
on new nutritional interventions based on PUFA in 
delaying the progress of inflammatory process and 
atherosclerosis in HD patients. The present study in-
dicates that higher as opposed to lower CRP levels 
are associated with poor prognosis in HD patients. 
The inflammatory cytokines are aggravated patients 
with an altered nutritional status.
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